🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07012785
Starting soon Not applicable

Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection

NCT07012785 · tracked via the Priya Life Science China tracker
Sponsor
Zhongda Hospital
Phase
Not applicable
Started
2025-06
Last updated
2025-06-10

Condition(s) studied

H. Pylori Infection

Investigational drug(s) / intervention(s)

Bismuth quadruple therapySaccharomyces boulardii

Bismuth quadruple therapy: Bismuth quadruple therapy

Saccharomyces boulardii: Saccharomyces boulardii

Study summary

To assess the efficacy and safety of Saccharomyces boulardii combined with triple therapy containing minocycline in the initial eradication of Helicobacter pylori (H. pylori) infection

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: 1. Aged 18-70 years, regardless of gender; 2. Positive 13C/14C urea breath test result; 3. No previous history of H. pylori eradication treatment; 4. Agreement to participate in this study and signing of the informed consent form. Exclusion Criteria: 1. History of ≥ 1 instance of failed H. pylori eradication; 2. Use of antibiotics (including antibacterial traditional Chinese medicines), nonsteroidal anti-inflammatory drugs (NSAIDS), bismuth agents, H2 receptor antagonists (H2RAs), proton-pump inhibitors (PPIs), and potassium-competitive acid blockers (P-CAB) within 4 weeks before treatment; 3. Plans to conceive, pregnancy, or breastfeeding; 4. Severe liver, kidney, or cardiovascular diseases; malignancies; and alcoholism; 5. Allergies to the drugs used in this study or a history of penicillin allergy; 6. The inability to correctly express one's symptoms and wishes, such as inability due to mental illness or severe neurosis.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhongda Hospital Southeast University Nanjing Jiangsu

More Zhongda Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07012785 on ClinicalTrials.gov ↗ ← All trials in China